Company / Net Income
Ligand Pharmaceuticals, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$124.5M
FY2025
5-year range
-$33.4M / $124.5M
FY2021-FY2025
Trend
+3186.6%
vs FY2024
Sector context
#41 of 216
Health Care
What the data says
Net Income changed +3187% YoY in FY2025, a notable deviation from the 9-year average annual change of +815%.
Based on SEC 10-K filings.
$124M in FY2025. Top quartile in the Health Care sector.
Improved from $52M to $124M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 216This company $124.5M Sector average $454.3M
▼
-72.6% below sector average
Key checks
Key Insights
- In FY2025, net income increased 3186.6% year-over-year.
- Ranks #41 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $124.5M | +3186.6% |
| FY2024 | -$4.0M | -107.7% |
| FY2023 | $52.2M | +256.3% |
| FY2022 | -$33.4M | -158.4% |
| FY2021 | $57.1M | +2014.2% |
| FY2020 | -$3.0M | -100.5% |
| FY2019 | $629.3M | +339.1% |
| FY2018 | $143.3M | +1041.5% |
| FY2017 | $12.6M | +867.5% |
| FY2016 | -$1.6M | -100.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026